Rossby Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$377K Buy
6,038
+1,753
+41% +$111K 0.06% 305
2026
Q2
$247K Sell
4,285
-1
-0% -$57 0.05% 344
2026
Q1
$265K Buy
4,286
+1,222
+40% +$71.2K 0.05% 311
2025
Q4
$165K Buy
3,064
+431
+16% +$20.7K 0.05% 311
2025
Q3
$125K Buy
2,633
+73
+3% +$3.41K 0.04% 359
2025
Q2
$119K Buy
2,560
+521
+26% +$25.6K 0.04% 338
2025
Q1
$97.7K Buy
+2,039
New +$119K 0.04% 342

Other funds holding BMY

Rossby Financial's BMY Position: Q3 2026 in Review

Rossby Financial increased its Bristol-Myers Squibb (BMY) stake by 41% in Q3 2026, buying an estimated $111K and bringing the position to 6,038 shares worth $377K. The position accounts for 0.06% of the portfolio, ranked #305.

Rossby Financial first reported a position in BMY in Q1 2025 and has held it in 7 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • Rossby Financial held 6,038 shares of Bristol-Myers Squibb worth $377K as of Q3 2026.
  • Rossby Financial bought 1,753 Bristol-Myers Squibb shares in Q3 2026, an estimated $111K.
  • Bristol-Myers Squibb made up 0.06% of Rossby Financial's portfolio in Q3 2026, its #305 holding.
  • Rossby Financial first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 7 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.